One must not forget that tissue engineering was first introduced as a life saving procedure for burn patients (1). The successful engraftment of autologous epidermal sheets was the first proof of concept of the powerful technology that we know today (2-4). However this very interesting initial approach fell into some disrepute because of perceived drawbacks and limitations (5, 6).
The subsequent efforts in the field followed essentially three "schools" of thought. The first approach consists in the seeding of cells into various gels, which are then reorganized, by the incorporated cells (7-14). Alternatively, a second approach is to seed cells into a scaffold where they will thrive and secrete extracellular matrix (15-17). The scaffold materials are bioresorbable over a wide range of time periods depending on their chemical structures (18) (19) (20) (21) (22) (23) (24) (25) . A third approach is different since it uses the principle of a tissue template that allows, after implantation, the ingress of cells into the appropriately organized scaffold. Thus, these grafts are acellular and must stimulate the regenerative potential of the tissue wherever they are implanted (26-31).
Our group has developed a different and original method for the reconstruction of soft tissues. It takes full advantage of the various intrinsic properties of cells when appropriately cultured. This entails particular media composition and appropriate mechanical straining of these threedimensional structures.
General principles of the self-assembly approach to tissue engineering
Our own experience with the culture of autologous epidermal sheets gave us some insight in the properties of cells to recreate in vitro a tissue-like structure. The resultant epidermis was thin but well organized.
Our various adaptations of the gel construct approach has shown that cells could be aligned along with their extracellular matrix if the mechanical forces generated were appropriately harnessed: either passively, by matrix anchorage (32), or actively, by cyclic traction of these constructs (12).
The self-assembly approach is a distillation of all these results. Basically, we coax the cells into secreting their own extracellular matrix in a sheet form. Thereafter, we either roll or stack these sheets to create a three-dimensional organ substitute. Our concept has been applied with some impressive results to the reconstruction of blood vessel and skin (33, 34).
The resulting living substitutes have no biomaterial and the extracellular matrix is not extraneous but corresponds to the cell's optimal need. We feel that such living substitutes have a distinct advantage over the other methods in their integrative characteristics into the human body. These substitutes are then as close as possible to the original tissue. The following examples will explain in more details this self-assembly approach.
Small diameter tissue-engineered blood vessels
The grafting of commercially available vascular synthetic prostheses is adequate for the replacement of large arteries (35). However, long-term patency results when small diameter blood vessels (< 5 mm) are concerned (limb salvage or coronary replacement for example) have been dismal. Indeed, the thrombogenic properties of the biomaterials associated with the low blood flow in these arteries are responsible for the formation of blood clots and obstruction of the conduit in many cases (36-38). The alternative approaches using allogenic or xenogenicallytreated implants have given few encouraging results because of the high percentage of prostheses degradation over time in long term implantation (39-42).
Another approach searched to combine the advantages of the synthetic grafts with the biological characteristics of an active endothelial intima (43, 44). Many investigators have then tried to seed endothelial cells (44-51), mesothelial cells (52, 53) or bone marrow cells (54, 55) upon the synthetic grafts. These attempts have been hampered by the weak attachment of endothelial cells to these various surfaces. The cells were dislodged by the arterial flow and consequently their physiological function also disappeared (56) (57) (58) (59) . However, this field is still very active with various methods directed towards better anchoring of the endothelial cells (44, [60] [61] [62] [63] [64] and consequently enhanced clinical results (65, 66) .
The first attempt to produce a reconstructed blood vessel by tissue-engineering methods appeared in 1986 with the model presented by Weinberg and Bell (8). The method devised by these researchers was based on collagen gels seeded with bovine vascular cells. Such a technique was at the basis of subsequent research conducted by other teams (9, 67, 68) . But the resulting structures were not resistant enough to sustain normal blood pressure (8, 9) and some of these prostheses had to be reinforced with a synthetic mesh (8, 69) making them hybrid artificial substitutes (composed of living cells in association with a synthetic support) with all the untoward properties associated with such constructions.
Since the previous approaches did not seem to be conducive to an acceptable clinical result, we developed a tissue-engineered blood vessel (TEBV) based exclusively on the use of human cells in the absence of any synthetic or exogenous material (33). This prosthesis was shown to have a supra-physiological blood pressure resistance and a morphological organization comparable to that of a native artery. ♦ From cells to the reconstructed vessel:
The cells used for such a TEBV were endothelial cells (EC), smooth muscle cells (SMC) isolated from human umbilical cord vein using an enzymatic method for EC (70) and the method of Ross for SMC isolation (71) . The fibroblasts were provided by the enzymatic treatment of a small biopsy of human skin (10, 72). The cells were characterized in culture to ensure their purity and their phenotype, then multiplied in vitro, in order to obtain enough cells for the reconstruction of each layer of the vascular wall: the intima (composed of EC), the media and the adventitia. In order to obtain an abundant extracellular matrix production, fibroblasts and SMC were cultured in media supplemented with ascorbic acid until they self-assembled into sheet that could be detached from the culture support and then be wrapped around a tubular mandrel. According to this methodology, the steps necessary to produce a complete blood vessel were the following: the SMC sheet was rolled over an acellular inner membrane (dehydrated tubular tissue formed with a fibroblast sheet) to form the media. After one week of media maturation, a fibroblast sheet was wrapped around the media layer to produce the adventitia, which was kept in culture during 8 weeks for the maturation process. Finally, after removing the tubular mandrel, EC were seeded on the inner membrane by injection into the lumen to form a confluent endothelium. The macroscopic view of the TEBV is presented in figure 1 . ♦ Mechanical, histological and physiological properties of the TEBV:
Although completely biologic, this reconstructed blood vessel was highly resistant with a burst strength of over 2500 mm Hg ( figure 2B ). This resistance is significantly higher than that of the human saphenous vein, considered to be the best biological material for lower limb vascular reconstruction (73, 74) . Moreover, this resistance of the matured vessel was constant over time, an important property not shared with previous models since they showed a decreasing resistance over the time (8). This impressive resistance is due to the well-organized extracellular matrix composed of collagen fibrils that were oriented in perpendicular directions to one another in the concentric layers of the adventitia ( figure 2A ). Moreover, a constant gelatinase activity was measured starting at 7 weeks of adventitia maturation. Finally, our TEBV showed the presence of elastic fibers, a crucial component of the extracellular matrix sorely lacking in other reconstructed models (8). All these critical characteristics were obtained even without pulsatile conditions of culture, which could, if applied, only improve the present model.
The media layer of the TEBV was tested for vasoreactivity to agonists and showed a contractile response to histamine in a similar fashion to the umbilical artery used as control (unpublished data).
Histological and immunohistological analyses of the TEBV showed cells surrounded by a dense extracellular matrix composed of collagen and elastin. Interestingly, desmin, a protein component of the cellular intermediate filaments, known to be lost in culture (75, 76) , is reexpressed in SMC of the TEBV. This result indicates how close to its physiological counterpart our model is. Only quiescent SMC can produce such a molecule.
The EC seeded on the inner membrane formed a confluent monolayer (figure 1) expressing von Willebrand factor and the cells were able to incorporate acetylated low-density lipoproteins. This endothelium inhibited platelet adhesion in contrast to the non-endothelialized acellular membrane. Thus, this endothelium was functional and provided an anti-thrombotic surface (33).
These human TEBVs were implanted for one week in femoro-femoral interposition in the dog. Because of the xenogeneic situation, the prostheses did not contain EC. The implanted prostheses demonstrated that they could be easily handled and sutured by the use of conventional surgical techniques. A patency level of fifty percent was obtained after one week of implantation and the patent implants were exempt of early tearing or dilatation (33).
Thus, the TEBV we have produced offers exciting perspectives in clinical as well as in pharmacological applications. Presently, its production in vitro takes around three months but this relatively long delay could be largely compensated by the benefit of producing autologous implants for patients in possible future clinical applications and experiences are being conducted to ensure its long term stability after implantation. Furthermore, appropriate culture condition under pulsatile flow should decrease the production time of these TEBV.
Skin equivalent elaboration by self-assembly approach
We recently fabricated the first skin equivalent composed exclusively of human cells into which pilosebaceous units were integrated (34). This could be the first step to more complex skin reconstruction by the self-assembly approach.
Fibroblasts, isolated from the dermal portion of skin biopsies and multiplied in vitro (10, 72) were cultured for 35 days in medium supplemented with ascorbic acid in order to increase the production of extracellular matrix and form sheets of cells (33). The latter were then peeled from the culture support and four layers were superimposed. The construction was maintained by a stainless steel anchoring ring for one week in order to allow further cell-matrix reorganization. Hair follicles were obtained by enzymatic treatment and forceps extraction from normal skin (removed during reductive breast surgery). The hair follicles were inserted in holes made in the multilayer dermal equivalent and an additional fibroblast sheet was added underneath the hair follicle. One week later, keratinocytes were seeded and cultured until confluence occurred (one week). Finally, the skin equivalent was maintained for 21 days at an air-liquid interface to induce the cornification of the epidermal layer (34, 77). ♦ Characteristics of the skin equivalent:
The upper layer (epidermis) at the air-liquid interface became dry and smooth and showed a visibly shiny surface. Photonic and transmission electron microscopy analyses revealed cell stratifications (cuboidal in the basal layer with hemidesmosomes, cells becoming flat and elongated in the supra-basal layers) and the expression of typical markers of keratinocyte differentiation (keratin 10, filaggrin and transglutaminase). The dermal portion displayed a remarkably "tissue-like" organization, with abundant collagen fibrils organized in parallel bundles perpendicular to one another and parallel to the epidermal surface like a normal dermis (figure 3C). One major and interesting property displayed by our skin model was the development of highly differentiated structures: a continuous basal lamina, characterized by the expression of laminin and collagen types IV and VII (figure 4), and separated from the basal keratinocytes by a clear and distinct lamina lucida (figures 3A and 3B). We also observed the presence of numerous anchoring zones with keratin intermediate filaments attached to the dense plaque of the hemidesmosomes of basal keratinocytes (figures 3A and 3B). Moreover, the complete lamina densa was observed after only four weeks of coculture, thus one week before the remarkable observations made by Contard et al. (78) . The hair follicle included in the model adapted its form to the insertion cavity and the follicle differentiation pattern was maintained: a basement membrane was detected at the dermal-follicular junction (laminin and type IV collagen production) as was a repartition of the filaggrin, keratin 10 and transglutaminase markers identical to that of a normal skin follicle. Expression of trichohyalin, a hair-specific protein, was also detected (34).
This fully tissue-engineered skin equivalent showed an excellent reorganization containing highly differentiated and rapidly formed structures closely identical to the original skin. Thus, the selfassembly approach allowed the in vitro reconstruction of a new histological-like model, which could be useful for the understanding of the mechanisms governing the interaction of cells and cell-matrix organization.
Conclusions
The self-assembly method for organ and tissue reconstruction is a truly different approach in the field of tissue engineering of soft tissues (33, 34) . This methodology demonstrated that the association of cells in well defined conditions (spatial as well as nutritional), was able to induce the reorganization of a complete tissue by various cells and to induce many of the physiological cellular properties lost in traditional bidimensional culture conditions (33). The integration of various tissues and organs created by such a method should be more rapid and without the resorption phase that characterizes the scaffold approach. Indeed, any synthetic or biosynthetic material has to be degraded by the implanted patient. This has lead to a chronic inflammatory reaction in many instances. The self-assembly approach is more akin to the physiological phenomenon that occurs in the womb during organogenesis. This may prove to be a distinct advantage for certain type of grafts.
Furthermore, our research team has used various tissue-engineering approaches with success for the reconstruction of skin (10, 16, 34, 79, 80), blood vessels (9, 33), ligaments (11, 12), bronchi (81) and cornea (14), but the production of more complex organs will necessitate a better understanding of the cellular biology and physiology of the cell-cell and cell-matrix interactions.
These advances in tissue engineering will help in numerous areas of research on physiological, pathophysiological and pharmacological mechanisms, allowing a better comprehension of these processes and the emergence of new methodologies to produce tissue-engineered implants, which could then solve the dramatic problem of organ supply. The LOEX was the first research group in Canada dedicated to the reconstruction of tissues by human cell culture. In 1986, this unique initiative allowed the first autologous transplant of reconstructed epidermis for the treatment of extensively burned patients in Canada. Dr Auger has overseen and participated in the diversification of his team's research interests into the domain of complete skin, blood vessels, ligament, cartilage, bronchi and cornea tissue engineered substitutes. He has published more than 50 articles and 200 abstracts in the field of tissue engineering. Recently, the LOEX developed a new tissue engineering approach aptly named the "self-assembly approach". It was applied to blood vessel reconstruction and to a novel reconstructed skin substitute. These engineered tissues are developed for experimental (physiological, pharmacological, mechanical) and future clinical purposes. The research group now has more than 30 members, from research assistant to senior investigators. Dr Auger is presently involved in the care of patients with tissue-engineered medical products and has set up a complete team (physician, nurse, regulatory affairs personnel) to conduct clinical trials for the evaluation of implanted grafts. Thus the LOEX is poised to expand its scientific activity in tissue engineering from fundamental problems all the way to bedside applications. The scope of this endeavor can be further appreciated at the LOEX's web site: www.loex.ulaval.ca.
